Nothing Special   »   [go: up one dir, main page]

ATE239750T1 - 6,11-verbrückte erythromycinderivate - Google Patents

6,11-verbrückte erythromycinderivate

Info

Publication number
ATE239750T1
ATE239750T1 AT98956314T AT98956314T ATE239750T1 AT E239750 T1 ATE239750 T1 AT E239750T1 AT 98956314 T AT98956314 T AT 98956314T AT 98956314 T AT98956314 T AT 98956314T AT E239750 T1 ATE239750 T1 AT E239750T1
Authority
AT
Austria
Prior art keywords
erythromycin derivatives
bridged erythromycin
bridged
derivatives
erythromycin
Prior art date
Application number
AT98956314T
Other languages
English (en)
Inventor
Yat Sun Or
George Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE239750T1 publication Critical patent/ATE239750T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98956314T 1997-10-29 1998-10-29 6,11-verbrückte erythromycinderivate ATE239750T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
ATE239750T1 true ATE239750T1 (de) 2003-05-15

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956314T ATE239750T1 (de) 1997-10-29 1998-10-29 6,11-verbrückte erythromycinderivate

Country Status (23)

Country Link
EP (1) EP1027361B1 (de)
JP (1) JP2001521038A (de)
KR (1) KR20010031591A (de)
CN (1) CN1278266A (de)
AR (1) AR015986A1 (de)
AT (1) ATE239750T1 (de)
AU (1) AU1286799A (de)
BG (1) BG104425A (de)
BR (1) BR9813317A (de)
CA (1) CA2307828A1 (de)
CO (1) CO4990972A1 (de)
DE (1) DE69814441T2 (de)
DK (1) DK1027361T3 (de)
ES (1) ES2198766T3 (de)
HU (1) HUP0004323A2 (de)
IL (1) IL134996A0 (de)
NO (1) NO20002099L (de)
PL (1) PL340253A1 (de)
PT (1) PT1027361E (de)
SK (1) SK6342000A3 (de)
TR (1) TR200001140T2 (de)
TW (1) TW486485B (de)
WO (1) WO1999021864A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
US6713455B2 (en) 2001-09-17 2004-03-30 Ortho-Mcneil Pharmaceutical, Inc. 6-O-carbamate-11,12-lacto-ketolide antimicrobials
WO2003050132A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
CA2483875C (en) * 2002-05-13 2008-09-23 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
KR100661973B1 (ko) 2002-05-13 2006-12-28 이난타 파마슈티칼스, 인코포레이티드 6,11 바이사이클릭 에리스로마이신 유도체
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
WO2018201076A2 (en) * 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0876388T3 (da) * 1995-11-08 2004-06-07 Abbott Lab Tricykliske erythromycinderivater

Also Published As

Publication number Publication date
KR20010031591A (ko) 2001-04-16
BR9813317A (pt) 2000-08-22
JP2001521038A (ja) 2001-11-06
CA2307828A1 (en) 1999-05-06
DE69814441D1 (de) 2003-06-12
AU1286799A (en) 1999-05-17
DE69814441T2 (de) 2004-04-08
CO4990972A1 (es) 2000-12-26
TR200001140T2 (tr) 2001-05-21
BG104425A (bg) 2001-01-31
TW486485B (en) 2002-05-11
PT1027361E (pt) 2003-09-30
EP1027361B1 (de) 2003-05-07
AR015986A1 (es) 2001-05-30
WO1999021864A1 (en) 1999-05-06
SK6342000A3 (en) 2000-09-12
NO20002099L (no) 2000-06-29
NO20002099D0 (no) 2000-04-25
PL340253A1 (en) 2001-01-29
CN1278266A (zh) 2000-12-27
DK1027361T3 (da) 2003-08-25
ES2198766T3 (es) 2004-02-01
HUP0004323A2 (hu) 2001-02-28
EP1027361A1 (de) 2000-08-16
IL134996A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
ATE377018T1 (de) Erythromycinderivate
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
LV11898A (lv) Eritromicina atvasinajumi
ATE234839T1 (de) 4,5-azolo-oxindole
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1027361

Country of ref document: EP

REN Ceased due to non-payment of the annual fee